# Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver

> **NCT00030563** · PHASE2 · COMPLETED · sponsor: **University of Washington**

## Conditions studied

- Colorectal Cancer
- Metastatic Cancer

## Interventions

- **DRUG:** irinotecan hydrochloride
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** radiofrequency ablation

## Key facts

- **NCT ID:** NCT00030563
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** 2004-10
- **Final completion:** 2005-10
- **Target enrollment:** — (—)
- **Last updated:** 2017-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00030563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00030563, "Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00030563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*